6 Results for "

biased agonism

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "biased agonism" in MCE Product Catalog:

Cat. No.: HY-P11043
GEP44 is a peptide biased triple agonist targeting Glucagon-like peptide 1 receptor (GLP-1R), neuropeptide Y1 Receptor (Y1-R), and neuropeptide Y2 Receptor (Y2-R). GEP44 induces Y1-R antagonist-controlled, GLP-1R-dependent stimulation of insulin secretion in both rat and human pancreatic islets by counteracting effects of Y1-R and GLP-1R agonism. GEP44 promotes insulin-independent Y1-R-mediated glucose uptake in muscle tissue and significantly reduces food intake and body weight in diet-induced obese rat models. GEP44 can be used for obesity and type 2 diabetes mellitus research .
loading...
    loading...
Cat. No.: HY-114978
CAS No.: 1428630-85-6
Purity:  99.84%
Target:  

mGluR PERK

Research Areas:  

Neurological Disease

VU0424465 is a potent and partial PAM (positive allosteric modulator)-agonist for mGlu5 mediated iCa 2+ mobilization. VU0424465 exhibits high affinity at MPEP allosteric binding site, with a Ki value of 11.8 nM. VU0424465 is also a agonist for pERK1/2 in cortical neurons .
loading...
    loading...
Cat. No.: HY-151515
CAS No.: 1610591-93-9
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Dopamine D2 receptor agonist-2 (compound 36) is a potent dopamine D2 receptor biased agonism ligand with an Ki value of 11.2 nM. Dopamine D2 receptor agonist-2 can be used to research antipsychosis .
loading...
    loading...
Cat. No.: HY-167216
CAS No.: 215997-93-6
Target:  

GPR84

Research Areas:  

Inflammation/Immunology

PSB-15160 is a human GPR84 agonist with EC50 values of 0.0800 μM and 4.33 μM, and selectivity versus FFAR1, FFAR4, and arylhydrocarbon receptor. PSB-15160 exhibits biased agonism, ago-allosteric action, and structure-activity relationships differing between cAMP and β-arrestin assays. PSB-15160 shows increased stability relative to the lead structure 3,3'-diindolylmethane .
loading...
    loading...
Cat. No.: HY-145156
CAS No.: 2212020-93-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

CHU-128 is an effective and selective GLP-1R agonist. CHU-128 exhibits strong signal specificity and can activate the Gs/cAMP pathway, but it cannot activate the Gq/calcium signal, ERK phosphorylation, or recruit β-inhibitory proteins. CHU-128 can be used for research on type 2 diabetes .
loading...
    loading...
Cat. No.: HY-179721
CAS No.: 923714-61-8
Research Areas:  

Neurological Disease

CCKBR agonist-2 (Compound z-44) is a Gi-preferring CCKBR agonist. CCKBR agonist-2 effectively activates the CCKBR-Gi signaling pathway (EC50 = 0.27 nM), but has almost no activity on Gq and Gs signaling pathways. CCKBR agonist-2 shows no significant protective effect in the mouse Alzheimer's disease model, proving that the simple activation of the Gi signal pathway does not play a dominant role in the improvement of cognitive function .
loading...
    loading...